{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Rocket Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"RCKTW"},"Address":{"label":"Address","value":"9 CEDARBROOK DRIVE,SUITE 7530, THE EMPIRE STATE BUILDING,SUITE 7530, THE EMPIRE STATE BUILDING, CRANBURY, New Jersey, 08512, United States"},"Phone":{"label":"Phone","value":"+1 609 659-8001"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis."},"CompanyUrl":{"label":"Company Url","value":"https://www.rocketpharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Gaurav D. Shah","title":"Chief Executive Officer & Director"},{"name":"Jonathan David Schwartz","title":"Chief Medical & Gene Therapy Officer"},{"name":"Kinnari Patel","title":"President, Chief Operating Officer, Head-R&D"},{"name":"Mayo Pujols","title":"Chief Technical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}